Wigginton Jon Marc 4
4 · MACROGENICS INC · Filed Jan 18, 2018
Insider Transaction Report
Form 4
MACROGENICS INCMGNX
Wigginton Jon Marc
Senior VP, Clinical Dev.
Transactions
- Sale
Common Stock
2018-01-16$20.00/sh−2,476$49,520→ 30,000 total - Exercise/Conversion
Common Stock
2018-01-16$4.70/sh+2,476$11,637→ 32,476 total - Exercise/Conversion
Common Stock
2018-01-17$4.70/sh+2,524$11,863→ 32,524 total - Sale
Common Stock
2018-01-17$20.00/sh−2,524$50,480→ 30,000 total - Exercise/Conversion
Employee stock option (right to buy)
2018-01-16−2,476→ 47,972 totalExercise: $4.70From: 2014-01-18Exp: 2023-07-18→ Common Stock (2,476 underlying) - Exercise/Conversion
Employee stock option (right to buy)
2018-01-17−2,524→ 45,448 totalExercise: $4.70From: 2014-01-18Exp: 2023-07-18→ Common Stock (2,524 underlying)
Footnotes (4)
- [F1]This amount includes 30,000 Restricted Stock Units (RSU) acquired on 2/25/16 which will vest on 2/25/18.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017.
- [F3]This transaction was executed in multiple trades at prices ranging from $20 to $20.71.
- [F4]This transaction was executed in multiple trades at prices ranging from $20 to $20.03.